Background: Voriconazole is widely used in the treatment of life-threatening invasive fungal infections (IFIs). The use of voriconazole is problematic due to its highly variable pharmacokinetics and narrow therapeutic index which complicate dosage selection and adjustment; few population pharmacokinetic data are available. Aim: This study aimed to develop a voriconazole population model incorporating data from […]
